273 related articles for article (PubMed ID: 19523504)
1. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
Kalaitzakis ME; Pearce RK; Gentleman SM
Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
[TBL] [Abstract][Full Text] [Related]
2. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.
Kalaitzakis ME; Christian LM; Moran LB; Graeber MB; Pearce RK; Gentleman SM
Parkinsonism Relat Disord; 2009 Mar; 15(3):196-204. PubMed ID: 18602855
[TBL] [Abstract][Full Text] [Related]
3. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
4. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
Walker L; Simpson H; Thomas AJ; Attems J
Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
[TBL] [Abstract][Full Text] [Related]
7. Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes.
Kalaitzakis ME; Walls AJ; Pearce RK; Gentleman SM
Neurobiol Dis; 2011 Feb; 41(2):377-84. PubMed ID: 20951207
[TBL] [Abstract][Full Text] [Related]
8. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
9. Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia.
Tilley BS; Patel SR; Goldfinger MH; Pearce RKB; Gentleman SM
J Parkinsons Dis; 2021; 11(4):1641-1650. PubMed ID: 34334423
[TBL] [Abstract][Full Text] [Related]
10. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
11. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
12. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
13. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
[TBL] [Abstract][Full Text] [Related]
14. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease.
Halliday GM; Song YJ; Harding AJ
J Neural Transm (Vienna); 2011 May; 118(5):713-9. PubMed ID: 21479514
[TBL] [Abstract][Full Text] [Related]
15. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis.
Chin KS; Yassi N; Churilov L; Masters CL; Watson R
Parkinsonism Relat Disord; 2020 Nov; 80():184-193. PubMed ID: 33260030
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.
Frigerio I; Bouwman MMA; Noordermeer RTGMM; Podobnik E; Popovic M; Timmermans E; Rozemuller AJM; van de Berg WDJ; Jonkman LE
Acta Neuropathol Commun; 2024 Jan; 12(1):4. PubMed ID: 38173031
[TBL] [Abstract][Full Text] [Related]
18. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
[TBL] [Abstract][Full Text] [Related]
19. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
Jellinger KA
Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]